Skip to main navigation Skip to search Skip to main content

Growth inhibition observed following administration of an LHRH agonist to a clonal variant of the MCF-7 breast cancer cell line is accompanied by an accumulation of cells in the G0/G1 phase of the cell cycle

Research output: Contribution to journal › Article › peer-review

Original languageEnglish
Pages (from-to)930-2
Number of pages3
JournalBritish Journal of Cancer
Volume63
Issue number6
DOIs
Publication statusPublished - Jun 1991

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Breast Neoplasms
  • Buserelin/pharmacology
  • Cell Cycle/drug effects
  • Cell Line
  • Clone Cells
  • Female
  • G1 Phase/drug effects
  • Gonadotropin-Releasing Hormone/antagonists & inhibitors
  • Humans
  • Kinetics
  • Resting Phase, Cell Cycle/drug effects

Cite this